Spike in antibiotic use during coronavirus pandemic could lead to more resistant bacterial infections: Experts

  27 April 2020

Complications from COVID-19 could potentially fuel antibiotic resistance, and lead to more resistant bacterial infections, warn scientists. While SARS-CoV-2, the pathogen responsible for COVID-19, is a virus, the disease can lead to conditions that require antibiotic treatment, including bacterial pneumonia, say experts. 

Antibiotic resistance is a serious worldwide threat to public health, says the WHO. Experts say in severe cases, it can be difficult to determine if pneumonia in a COVID-19 patient is viral or bacterial in nature, and the severity of the condition may require urgent action. The incorrect administration of antibiotics is secondary to the main goal of saving lives, but some experts are highlighting this as a growing concern. A myriad of complex factors could impact antimicrobial resistance (AMR) in the US and around the world, they caution. 

Further reading: MEAWW
Author(s): Mihika Basu
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed